Combination therapy reduced dense VLDL cholesterol significantly more than did fenofibrate or simvastatin monotherapy, the investigators found. Simvastatin lowered intermediate density lipoprotein (IDL) cholesterol significantly more than did fenofibrate.
英
美
- 研究者發(fā)現，聯(lián)合治療相對于但用非諾貝特或辛伐他汀顯著(zhù)的降低極低密度脂蛋白膽固醇的密度。辛伐他汀比非諾貝特降低中等密度脂蛋白膽固醇的作用顯著(zhù)。
